This website uses cookies. By continuing to browse this website you are agreeing to our use of cookies. Find out more by reading our privacy policy. Read more
NN8640
:Growth disorder
:Phase 1
A long-acting human growth hormone intended to offer less frequent injections.
- Company announcements
- No company announcements matching the search criteria
- Press releases
- No press releases matching the search criteria
- Scientific abstracts
No scientific abstracts matching the search criteria
You can search for more clinical trials on http://clinicaltrials.gov








